Xenomics Closes $2.9 Million Financing

Xenomics, a developer of next-generation molecular diagnostic techniques for medical and life sciences applications, has announced the closing of a private placement financing totaling $2.9 million. The proceeds will fund expansion of the company's research and commercialization of its proprietary solutions in a range of key medical and life science markets.

MENAFN (http://menafn.com/qn_news_story.asp?StoryId=CqGgV0bKbmdm0yJu1mtG)